hers for semaglutide Hims? Hers? It's Novo Nordisk's Market Now Hims & Hers Weight Loss

Methods This retrospective cohort study included adults with overweight or obesity and 1 pharmacy claim for semaglutide 2.4 mg or tirzepatide in the US Komodo Health database between June 4, 2021, and December 15, 2023

Results Patients with a high cumulative dose of GLP-1 agonist are associated with a higher risk of developing drug-induced pancreatitis associated with GLP-1 agonists, indicated by a statistically significant odds ratio

This direct connection enables Sesame to offer doctor visits, labs, imaging and prescription drugs at half the price.

Some sub-analyses of large clinical trials suggest that GLP-1RA and sodium-glucose cotransporter 2 inhibitor combination therapy may provide more significant reductions in heart failure hospitalization and renal composite events than each alone

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy two days after it announced the new drug and one day after the Food and Drug Administration threatened to restrict access to t